SMTL ID : 7mxi.1

IgE-Fc in complex with DARPins E2_79 and E3_53

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

hetero-2-2-2-mer

Ligands

2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA.1: 7 residues within 4Å: Chain A: Y.41, V.63, L.65, Q.94, N.96, T.98, T.100 No protein-ligand interaction detected (PLIP) NAG-NAG-BMA.3: 8 residues within 4Å: Chain B: Y.41, L.61, V.63, L.65, Q.94, R.95, N.96, T.98 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:Y.41

1 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-FUC.2: 4 residues within 4Å: Chain B: N.73, T.75, R.121 Chain D: D.129 3 PLIP interactions: 2 interactions with chain B, 1 interactions with chain D Hydrophobic interactions: B:T.75 Hydrogen bonds: B:R.121, D:D.129

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Pennington, L.F. et al., Structure-guided design of ultrapotent disruptive IgE inhibitors to rapidly terminate acute allergic reactions. J.Allergy Clin.Immunol. (2021)

Release Date

2021-07-28

Peptides

IgE Fc: AB
DARPin E3_53: CE
Anti-IgE Inhibitor E2_79: DF

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

E
D

D
E

F
F

IgE Fc

DARPin E3_53

Anti-IgE Inhibitor E2_79

Related Entries With Identical Sequence